Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-03-09
1996-12-03
Davis, Zinna Northington
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514241, 514252, 514255, 514256, 514336, 514340, 514341, 514342, 514343, 514338, 544212, 544238, 544333, 544360, 544114, 546114, 546116, 546194, 546257, 5462684, 5462687, 5462691, 5462704, 5462721, 5462741, 5462764, 5462761, 5462754, 5462724, 5462804, 5462814, 5462834, 5462844, 5462847, C07D40514, A61K 3144
Patent
active
055808719
ABSTRACT:
There are provided novel 1,4-dihydropyridine compounds, compositions containing them and methods of using them to treat congestive heart failure.
REFERENCES:
patent: 4659717 (1987-04-01), Wikel
patent: 4902694 (1990-02-01), Holland et al.
Davis Zinna Northington
The DuPont Merck Pharmaceutical Company
LandOfFree
4-Heteroaryl- 1,4-dihydropyridine compounds with calcium agonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-Heteroaryl- 1,4-dihydropyridine compounds with calcium agonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-Heteroaryl- 1,4-dihydropyridine compounds with calcium agonist will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-785770